Vigil Neuroscience, Inc.
VIGL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $378,577 | $82,001 | $70,817 | $137,965 |
| - Cash | $41,214 | $51,620 | $39,019 | $44,896 |
| + Debt | $12,437 | $12,693 | $12,945 | $13,177 |
| Enterprise Value | $349,800 | $43,074 | $44,743 | $106,246 |
| Revenue | $0 | $0 | $452 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | -$124 | $226 | -$114 |
| % Margin | – | – | 50% | – |
| EBITDA | -$27,362 | -$22,289 | -$25,001 | -$20,562 |
| % Margin | – | – | -5,531.2% | – |
| Net Income | -$26,663 | -$22,413 | -$23,831 | -$19,258 |
| % Margin | – | – | -5,272.3% | – |
| EPS Diluted | -0.56 | -0.49 | -0.57 | -0.47 |
| % Growth | -14.3% | 14% | -21.3% | – |
| Operating Cash Flow | -$20,479 | -$23,893 | -$18,141 | $4,301 |
| Capital Expenditures | -$69 | -$285 | $0 | $0 |
| Free Cash Flow | -$20,548 | -$24,178 | -$18,141 | $4,301 |